Top 10 AI Prompts and Use Cases and in the Healthcare Industry in Ireland

AI matters in Irish healthcare because it turns scarce staff time and mountains of data into faster, fairer care: machines can triage scans, predict admissions and free clinicians from routine admin so patients move through the system sooner.

Ireland's Santáiche challenges - long waitlists and diagnostic pinch points that left “444 people on trolleys” on a single winter day - are exactly the problems AI can help solve, especially where radiology already benefits from a national digital scan library and local pilots have used AI to flag bleeds, clots and even generate “synthetic MRIs” from CTs (see the Mater case in the BBC report).

Policy and safety matter too: EU guidance and the HSE's AI roadmap stress human‑in‑the‑loop care, data quality and predictable regulation. Practical workforce upskilling and short courses are the bridge from pilots to safer, scalable deployments - start with accessible primers such as AI Ireland's comprehensive guide and the HSE's AI overview to understand what to adopt first.

Bootcamp	Length	Early bird Cost	Registration
AI Essentials for Work	15 Weeks	$3,582	Register for AI Essentials for Work bootcamp (15 Weeks)

“Now a nurse or junior doctor at 2am isn't alone, they've got a wing man,” says Prof Peter McMahon about AI support in radiology.

Methodology - How the Top 10 were selected for Ireland: selection prioritised real-world readiness and policy alignment rather than hypothetical promise - projects were scored on three Ireland‑specific filters drawn from recent national activity: data maturity and standards (the DCAM findings and SNOMED CT adoption under the HSE's Digital for Care roadmap), interoperability and EHDS compliance demonstrated in myHealth@EU test activity, and practical deployment readiness (talent, infrastructure and governance) highlighted in UK‑Ireland generative AI studies.

Sources informed a weighted shortlist: eHealth Ireland's summaries of the Ireland masterclass and the Digital for Care conference guided the standards and interoperability criteria (eHealth Ireland Digital for Care conference and SNOMED CT adoption), SFI/ADAPT research framed privacy‑preserving and regulatory checkpoints for safe AI use (SFI/ADAPT research on safe, responsible AI and EHDS readiness), and regional adoption signals from the Cognizant UKI study informed assessments of workforce and infrastructure readiness.

The outcome: solutions that score highly on standardised data, interoperability testing and demonstrable governance moved into the Top 10 shortlist - a pragmatic bar that reflects Ireland's national roadmaps and the EU regulatory horizon.

Criterion	Why it matters (Ireland)
Data standards & maturity (DCAM / SNOMED CT)	Ensures coded, reusable records for AI models and EHDS compliance
Interoperability / Test harness (myHealth@EU)	Validates cross‑system exchange and real-world integration
Deployment readiness (talent, infra, governance)	Reflects workforce, compute and ethical controls needed for safe rollout

“By giving partners in the healthcare data space a framework for understanding different regulatory and organisational policy constraints on data sharing we can ensure that data is shared in a way that respects the rights and freedom of users.” - Professor Dave Lewis

Ireland's first large‑scale hospital rollout of imaging AI gives a clear, practical picture of what diagnostic support can do: Aidoc's platform at the Mater Misericordiae University Hospital has run “always‑on” in the background to analyse more than 15,600 scans, flagging over 700 urgent findings within two to three minutes and correctly identifying roughly 500 intracranial haemorrhages and 200 pulmonary emboli - results the hospital says are over 90% accurate and which have sped up emergency decisions and reduced reporting turnaround.

Read the Mater deployment and technical overview on Aidoc's site and the Irish Times coverage for the clinical context, trial timelines and the hospital's plans to expand into bone and chest X‑ray tools.

This live example shows how a well‑governed, human‑in‑the‑loop approach can triage the caseload so radiologists focus on the sickest patients first, turning a data flood into a practical safety net for clinicians and patients alike.

Metric	Reported value (Mater Hospital)
Scans analysed	15,600+
Pathologies flagged	700+
Intracranial haemorrhages flagged	~500
Pulmonary emboli flagged	~200 (plus 50 incidental outpatient PEs)
Reported accuracy	More than 90%
Trial period	April–August (prior to full deployment)
Initial AI applications	CT pulmonary angiograms; CT head ICH detection; cervical spine fracture detection

“Our experiences have underscored the tangible benefits of AI, notably in expediting critical diagnoses and reducing turnaround times by rapidly flagging anomalies detected in scans.” - Professor Peter MacMahon, Consultant Radiologist

Predictive analytics aim to turn routine ward data into early warnings that catch patient deterioration before alarms sound; well‑known efforts such as the eCART family of models - developed from electronic health record data to predict adverse ward outcomes - show how vital-signs, labs and trends can be combined into actionable risk scores (eCART sepsis prediction model publications and studies).

Yet real‑world experience is mixed: a recent Sepsis Alliance webinar unpicks why many sepsis prediction models are failing in practice and argues for rethinking model design, evaluation and clinical workflows rather than blind deployment (Sepsis Alliance webinar recap on sepsis prediction model failures and Yale's eCART case study).

Newer models keep pushing the envelope - for example the VIOSync Sepsis Prediction Index claims the potential to forecast sepsis up to six hours before clinical onset, a lead time that in theory can turn a midnight sprint to ICU into a calm, planned intervention (VIOSync Sepsis Prediction Index preprint forecasting sepsis up to six hours).

For Ireland, the takeaway is pragmatic: these tools offer promise but must be locally validated, integrated with ward workflows and supported by clinician training so early warning becomes usable, not just visible.

Precision medicine in Ireland hinges on turning rich molecular data into clear, timely choices at the bedside, and platforms from Tempus and Foundation Medicine are built for exactly that: EHR‑integrated assistants, broad NGS panels, liquid biopsies and algorithmic tests that surface targeted therapies and trials.

Tempus packages tumor+liquid profiling, whole‑transcriptome RNA‑seq, MRD monitoring (xM) and an AI clinical assistant (Tempus One) with trial‑matching and care‑pathway tools so clinicians can find actionable options faster - its genomic profiling notes that dual tissue+liquid testing revealed unique actionable variants in ~9% of a metastatic pan‑cancer cohort and that RNA sequencing identified ~29% more fusion targets than DNA alone (Tempus genomic profiling).

Foundation Medicine's comprehensive genomic profiling aims to replace sequential single‑gene tests with one clinically actionable report and FDA‑approved companion diagnostics to increase treatment options (Foundation Medicine CGP).

For Ireland, the win is practical: EHR integration, smart reporting and trial‑matching can close biomarker testing gaps and convert previously missed mutations into real therapeutic paths, shaving weeks off decision time when every day counts.

Organisation	Selected metrics
Tempus	6.5K+ oncologists; 30K+ patients identified for trials; 8M+ de‑identified records; 40+ operational countries
Foundation Medicine	500k+ patient samples profiled; 65+ biopharma partnerships; 500+ peer‑reviewed publications; FDA‑approved tissue & liquid CDx

"Asking Tempus One a verbal question about the status of a test, results for a specific patient, or to look at trends across several patients is super intuitive and easy to use." - Thomas George, MD

Virtual health assistants and symptom‑checking chatbots offer a tempting shortcut for overburdened primary care services, but the Babylon saga is a clear warning for Ireland about hype outpacing evidence: reporters and former staff described flashy Knightsbridge offices, pizza‑fuelled teams and even a data scientist sleeping in the office to cobble together a demo for the BBC - yet regulators, clinicians and independent reviews repeatedly flagged safety, transparency and effectiveness concerns (WIRED investigation into Babylon Health's rise and fall and AI safety concerns; BBC report on Babylon Health's exam claims and triage tool controversy).

The practical lesson for Irish adopters is straightforward - focus narrowly on well‑validated, human‑in‑the‑loop triage that has been locally tested, demand clear evidence before procurement, and treat symptom checkers as workflow aids rather than replacements for clinical judgement; done right, a chatbot can routinise simple queries, but done wrong it risks amplifying waiting‑list problems instead of easing them.

“I was like, well, this isn't really artificial intelligence.” - Hugh Harvey, former Babylon consultant doctor

Remote patient monitoring is showing practical promise for Ireland where distance and delayed access matter: high‑quality evidence now exists that wearable ECGs plus AI can spot otherwise silent, high‑risk heart disease and that locally‑tested algorithms can improve rhythm detection.

The Mayo Clinic's app transmitted Apple Watch ECGs into a secure, EHR‑integrated dashboard and collected 125,610 tracings with 92% repeat use; its AI flagged 13 of 16 patients with ejection fraction ≤40% (AUC 0.875, sensitivity 81.2%), illustrating both sustained patient engagement and clinically meaningful yield (Mayo Clinic Apple Watch ECG app study).

At home in Dublin, a Beacon Hospital team found PulseAI's algorithm increased atrial‑fibrillation sensitivity by 18% versus Apple's ECG and cut unclassified readings from 10% to under 1% - a reminder that local validation matters before national adoption (Beacon Hospital PulseAI vs Apple ECG study).

For Irish services, the immediate tasks are simple and concrete: validate algorithms on local cohorts, link wearable streams into clinician workflows, and use these tools to triage scarce specialist time rather than replace it.

“We have seen how artificial intelligence has revolutionized the already common ECG into a tool that can be used to identify occult cardiovascular diseases.” - Zachi Itzhak Attia, MSEE, PhD, Mayo Clinic

AI is already reshaping the drug pipeline: Insilico's suite of generative tools moved at pace - taking an AI‑discovered candidate into first‑in‑human testing in under 30 months - and has advanced INS018_055 into Phase II, illustrating how target discovery, generative chemistry and machine learning can compress long development cycles (Insilico INS018_055 Phase II progress - Drug Discovery Trends); companion Phase 2a data for an AI‑designed candidate showed a clinically meaningful lung‑function gain (forced vital capacity +98.4 mL versus placebo), proof that AI‑originated molecules can produce human signals worthy of larger trials (Rentosertib Phase 2a results - Drug Discovery Trends).

For Irish biotech, the headline is practical: generative platforms can shorten timelines and surface novel targets, but success depends as much on clinical rigor and IP strategy as on model accuracy - issues explored in recent analyses of Insilico's approach to patents and disclosure (IPKat analysis of Insilico IP strategy - IPKat).

One vivid takeaway: a molecule born in silicon can reach patients' bedside trials faster than many expected, but regulators, safety signals and careful trial design remain the gatekeepers.

Candidate	Phase / Design	Key efficacy signal	Notable safety / notes
INS018_055 (Insilico)	Progressed to Phase II; randomized, double‑blind, placebo‑controlled	AI‑discovered, first‑in‑class anti‑fibrotic small molecule	Phase I topline positive; discovery→Phase I in under 30 months
Rentosertib (AI‑designed)	Phase 2a randomized, double‑blind, three‑dose vs placebo; 71 patients	Mean FVC +98.4 mL vs −20.3 mL for placebo	Seven discontinuations for liver injury or dysfunction reported; encouraging but small cohort

Administrative workflow automation in Ireland is already moving from pilot kits to practical wins: RPA and intelligent automation can sweep repetitive tasks off clinicians' desks so staff focus on patients, not paperwork - for example, automated billing and claims bots that “flag errors before they slow us down” cut delays and reduce costly rework (SmartFlow RPA benefits for healthcare and insurance billing).

Local pioneers show the pattern: clinical teams freed from data chores (infection‑control nurses in Dublin are a noted example) can redirect hours to care, while no‑code workflow builders let trust administrators spin up validated processes without long IT projects (FlowForma no-code healthcare automation for trusts).

That practical, governance‑first approach is echoed by vendors offering end‑to‑end intelligent automation and document processing that integrate with EHRs - a must for Irish trusts aiming to reduce waitlists and billing backlogs (Tungsten Intelligent Automation for healthcare document processing).

One vivid takeaway: a reliable bot that stops a duplicate invoice before it reaches the ledger can turn frantic month‑end reconciliations into a single calm click.

Administrative use case	Example vendor / source
Billing & claims processing	SmartFlow guide to RPA benefits
No‑code workflow creation for trusts	FlowForma no‑code platform
Interoperable EHR aggregation & automation	iEHR.ai (listed in StartUs report)
Intelligent document & AP automation	Tungsten Intelligent Automation

“Since we went live with AP Essentials, we've not had a single instance of a double payment: a 100 percent accuracy rate for the solution.”

Surgical robotics is moving from promise to practice as computer vision and AI begin to augment what surgeons already do best - improving visualization, stabilising instruments and enabling finer minimally invasive work - an evolution well captured in recent overviews of the field (Encord: The State of AI in Surgical Robotics).

International consensus guidance stresses that these systems remain surgeon‑controlled:

the surgeon sits at a console outside the sterile field

so safe adoption depends on formal training, proctoring, team rehearsal and robust privileging policies rather than one‑off demos (SAGES/MIRA Robotic Surgery Consensus Document).

Early AI add‑ons such as imaging overlays and augmented guidance already show promise for tighter resections and better intraoperative decisions, but the evidence base and outcomes registries must mature before widescale rollout (The Future of Artificial Intelligence in Surgery).

For Irish hospitals the practical takeaway is clear: treat robotics + AI as a systems project - invest in simulation and credentialing, build OR workflows that include human‑in‑the‑loop checks, and capture outcomes locally so machines become reliable teammates, not black‑box surprises.

Ambient scribes and AI note‑builders are moving from novelty to practical tools that can quietly unclog clinicians' days in Ireland: Nuance's DAX (Dragon Ambient eXperience) and the new Microsoft Dragon Copilot both capture multi‑party conversations, auto‑draft specialty notes, pull context from the chart and even suggest orders - all designed to reduce after‑hours typing and surface billable, codable detail for more timely reimbursement (Nuance DAX ambient clinical documentation infographic).

Microsoft's Dragon Copilot promises the same ambient capture plus generative summarisation and is slated to be generally available in the UK and Ireland in September 2025, making local pilots and EHR integration testing timely for Irish trusts (Microsoft Dragon Copilot clinical workflow overview).

Early vendor metrics sound attractive - minutes reclaimed per consult and lower burnout - but real gains depend on tight EHR workflows, local validation and preserving clinicians' “voice,” not simply swapping one admin chore for another (see clinicians' cautionary experience below) (Medscape clinician AI scribe trial and advice article).

Metric / Claim	Reported value / note
Time saved per encounter	~7 minutes (Nuance DAX infographic)
Reduction in documentation time	~50% (Nuance DAX infographic)
Reported burnout reduction	~70% fewer feelings of burnout (Nuance DAX infographic)
Availability in Ireland	Dragon Copilot: generally available in UK & Ireland, September 2025 (Microsoft)

“AI will not shrink ballooning patient panels or outmaneuver overloaded schedules. … Primary care clinicians will only reap the benefits of AI if it is implemented in organisations that sincerely prioritize clinician well‑being and patient care.” - John Thomas Menchaca, MD

Guideline and literature query tools that use retrieval‑augmented generation (RAG) - the technology behind modern assistants such as UpToDate Edge and Elsevier ClinicalKey GPT - promise a practical shortcut for busy Irish clinicians by pairing LLM fluency with vetted, citable sources; recent systematic reviews and meta‑analyses show RAG approaches reduce hallucinations and improve alignment with clinical evidence (see the PLOS Digital Health systematic review of retrieval-augmented generation at PLOS Digital Health RAG systematic review, the JAMIA meta-analysis of RAG clinical performance at JAMIA meta-analysis on retrieval-augmented generation, and the Mayo Clinic Platform overview at Mayo Clinic Platform overview of retrieval-augmented large language models).

The Mayo Clinic Platform summary also notes that RAG systems can outperform generic models when they draw on curated, expert‑validated corpora, but cautions that simulated test sets and structured inputs don't capture real ward messiness.

For Ireland that matters: any procurement should insist on local validation against HSE‑aligned guidelines, clear provenance and timestamps for returned citations, and human‑in‑the‑loop workflows so an assistant's answer comes with a linked guideline excerpt rather than a standalone verdict.

In short, RAG can turn a fraught literature trawl into a short, sourced answer - but only if Irish trusts demand rigorous testing, transparent sources and clinician oversight before relying on it in patient care.

Beginners in Ireland should take small, practical steps: learn the rules, validate locally and build skills that make you useful today. Start by reading the evolving policy landscape - Fieldfisher notes a national AI strategy for healthcare is expected in 2026, so procurement and safety rules will tighten (Fieldfisher analysis of Ireland AI strategy for healthcare) - and pair that with the HSE's pragmatic, human-in-the-loop framing of AI benefits and limits from eHealth Ireland before trialling any tool (eHealth Ireland AI and Automation Centre of Excellence guidance).

Practically, begin with a short, structured course that teaches tool use and prompt skills, then run a small local validation study with clinicians: a 15-week primer such as the AI Essentials for Work bootcamp gets non-technical staff prompt-ready and procurement-savvy so pilots become accountable deployments (AI Essentials for Work bootcamp registration).

The combination of policy awareness, local validation and practical upskilling turns cautious curiosity into safe, measurable progress for Irish services.

Bootcamp	Length	Early bird Cost	Registration
AI Essentials for Work	15 Weeks	$3,582	Register for AI Essentials for Work bootcamp

“Now a nurse or junior doctor at 2am isn't alone, they've got a wing man.” - Professor Peter McMahon